GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery  + Monitoring   + Drug Therapeutics   + Medical Devices  + Pain & CNS   + Tissue
 
Advanced Devices for Injectable Drugs
Products, Players and Prospects


About This Report

Price: US$2,850

Publication: January 2013

Product Code: ADJ417F







Drug Delivery Reports

Prefilled Syringes to 2016
Pen Injectors
Sustained Release Injectables
Injectable Drug Delivery 2016
Cartridge-based Injectors
Integrated Safety Syringes
Drug Reconstitution Systems
Autoinjectors to 2016
Dual Chamber Injectors
Needle-free Injectors
IV Fluid Transfer Devices
Smart Infusion Pumps
Inhaled Drug Delivery to 2016
Dry Powder Inhalation
Inhaled CNS Therapeutics
Pulmonary Inhalers
Inhaled Pain Management
Prescription Drug Patches
Microneedle Drug Delivery
Patch Pump Drug Delivery
Transdermal CNS Therapeutic
Needle Array Drug Delivery
Transdermal Pain Mgmt
Oral Transmucosal Delivery
Iontophoresis Drug Delivery
Therapeutic Proteins to 2016
Pediatric Drug Delivery
Closed Drug Transfer System
Drug Self-Administration 2016
Drug Solubiity
 
 
 
 
 
 
 
 
 
 
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines injection devices engineered with features that advance the state-of-the-art for injectable drugs, providing essential insight and forecasts into the implications of this evolving landscape.
Highlights

· Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injection devices on the competitive landscape

· Analyzes advanced syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

· Provides detailed descriptions advanced devices for injectable drugs and assesses the impact of advanced features on therapeutic segments

· Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations
Summary of Contents

Executive Summary

Injectable Drug Market Dynamics

The Injectable Drug Ecosystem
Therapeutic Demand Drivers
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market Drivers

Advanced Autoinjectors

Small Form Factor Devices
Oval Autoinjector (Oval Medical Technologies)
Advanced Safety & Easy-of-Use
Advanced Autoinjector Device Profiles
Variable Dose Autoinjectors
Variable Dose Autoinjector Profiles
Advanced Product Specific Autoinjectors

Advanced Pen Injectors & Specialty Syringes

Dual Chamber Injectors
  Syringe Devices
  Pen Injectors & Cartridges
Variable Dose Pens
Dose Memory Pens
Therapeutic Products
  Syringe Products
  Cartridge/Injector Products


Advanced Prefillable Syringes
Prefillable Safety Syringes
Tamper Evident Prefillable Syringes

Advanced Needle-free Injectors
Prefilled Needle-free Injectors

Market Factors

Regulations
Quality and Reliability
Managed Care and Healthcare Economics

Company Profiles




 

 

Recent Research

Prefilled Syringes to 2018

Pen Injectors

Drug Self-Administration

Injectable Drug Delivery to 2018

Autoinjectors to 2018


Events

Drug Delivery & Formulation Summit - San Diego (April 2013)

Partnerships in Drug Delivery  - Boston (October 2013)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2013 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career